Evaluating Lebrikizumab in Pigmented Skin

Name: Evaluating Lebrikizumab in Pigmented Skin
Uploaded: 2025-07-16T04:00:00+00:00
Duration: 4 min 23 s
Description: Andrew Alexis, MD, MPH, discusses new data presented at the Revolutionizing Atopic Dermatitis (RAD) Conference from the phase 3b Admirable trial, the first

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

The Significance of Tolerability and Persistent Efficacy in Pediatric Atopic Dermatitis
The Significance of Tolerability and Persistent Efficacy in Pediatric Atopic Dermatitis
Updates in Atopic Dermatitis
The Significance of Tolerability and Persistent Efficacy in Pediatric Atopic Dermatitis
Lawrence Eichenfield, MD, FAAD
Lawrence Eichenfield, MD, FAAD
Beyond Steroids: Advancing Topical AD Care
Beyond Steroids: Advancing Topical AD Care
Updates in Atopic Dermatitis
Beyond Steroids: Advancing Topical AD Care
Christopher Bunick, MD, PhD, FAAD
Christopher Bunick, MD, PhD, FAAD
Anti-OX40 Ligand Antibody Trials
Anti-OX40 Ligand Antibody Trials
Updates in Atopic Dermatitis
Anti-OX40 Ligand Antibody Trials
Stephan Weidinger, MD, PhD
Stephan Weidinger, MD, PhD
Chronic Hand Eczema
Chronic Hand Eczema
Updates in Atopic Dermatitis
Chronic Hand Eczema
Raj Chovatiya, MD, PhD, MSCI, FAAD
Raj Chovatiya, MD, PhD, MSCI, FAAD

VIDEOS

PODCASTS

COLUMNS

DERMWIRE NEWS

CONFERENCE COVERAGE

DERMATOLOGY HUB

Evaluating Lebrikizumab in Pigmented Skin

Recommended

Evaluating Lebrikizumab in Pigmented Skin

Recommended

Title